FCM
PHAS

Farallon Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Farallon Capital Management’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-84,502
Closed -$280K – 128
2020
Q1 		$280K Sell
84,502
-915,498
-92% -$3.03M ﹤0.01% 100
2019
Q4 		$6.11M Buy
1,000,000
+192,072
+24% +$1.17M 0.04% 103
2019
Q3 		$3.37M Buy
807,928
+50,967
+7% +$213K 0.03% 92
2019
Q2 		$9.93M Buy
+756,961
New +$9.93M 0.06% 86